相关实验视频

Updated: Jul 29, 2026

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

在阿伯丁皇家医院OPAT服务中,在各种格兰美阳性感染中使用达尔巴万辛的经验

James C McSorley¹, Darshini Reyes², Ivan Tonna³

¹School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.

|January 2, 2024

概括

达尔巴万辛有效治疗急性细菌性皮肤感染 (ABSSSI),并且在门诊环境中对深层感染有希望. 需要进一步的试验来确认其在复杂病例中的有效性.

科学领域:

传染性疾病传染性疾病
药理学药理学是指药理学的学科.
临床医学临床医学

背景情况:

达尔巴万辛已被批准用于治疗格拉姆阳性急性细菌性皮肤和皮肤结构感染 (ABSSSI).
它的药理动力学特征允许使用单剂或双剂方案.
达尔巴万辛可能适用于对深层感染的门诊亲肠道抗生素治疗 (OPAT),可能避免住院治疗.

研究的目的:

评估达尔巴万辛在现实世界临床实践中的有效性,用于各种适用于标签和非标签的适用于各种适用于标签和非标签的适用于各种适用于标签的适用于各种适用于标签的适用于各种适用于标签的适用于各种适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的适用于标签的
评估达尔巴万辛作为初级或连续的巩固疗法.
为了记录实用的dalbavancin使用的临床经验.

主要方法:

对2021年12月至2022年10月期间处方达尔巴万辛的患者进行了回顾性审查.
收集的数据包括患者人口统计,并发症 (查尔森并发症指数),过敏,病原体,达尔巴万辛剂量和同时使用抗生素.
主要结局是治疗治愈;次要结局包括不良事件和对治疗失败的救援疗法的反应.

主要成果:

观察到的整体治愈率为67%.
在ABSSSI (93%),细菌病 (100%) 和急性骨髓炎 (90%) 中发现了高治愈率.
慢性骨髓炎 (0%) 和假肢关节感染 (33%) 的治愈率较低,其中抑制治疗通常是目标,成功率分别为48%和66%. 14%的患者发生了不良事件.

结论:

这项研究支持达尔巴万辛用于ABSSSI的使用,并扩大了非标签指示的临床经验.
达尔巴万辛显示出作为治疗深层感染的初级治疗的潜力.
需要进一步的临床试验来研究达尔巴万辛在复杂,深层感染中的作用.

关键词:

细菌血症是什么意思细胞质炎是一种细胞质炎.达尔巴万辛 (Dalbavancin) 是一种葡萄酒.脂质甘油是一种脂质甘油.这就是OPAT OPAT.骨髓炎是一种骨质炎.

更多相关视频

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection

Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection

Published on: March 14, 2019

In Vivo Mouse Model of Spinal Implant Infection

In Vivo Mouse Model of Spinal Implant Infection

Published on: June 23, 2020

相关概念视频

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...

Acute Pyelonephritis II: Diagnostic Studies and Management

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Staphylococcal Skin Infections

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...

Bacterial Meningitis

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...